Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 29, 1999 - Issue 10
63
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Metabolic inactivation of 2-oxiranylmethyl 2-ethyl2,5-dimethylhexanoate (C10GE) in skin, lung and liver of human, rat and mouse

, , , &
Pages 987-1006 | Published online: 22 Sep 2008

References

  • BARBER, E. D., TEETSEL, N. M., KOLBERG, K. F. and GUEST, D., 1992, A comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skin. Fundamental and Applied Toxicology, 19, 493–497.
  • BENTLEY, P., BIERI, F., KUSTER, H., MUAKKASSAH -KELLY, S., SAGELSDORFF, P., STÄUBLI, W. and WAECHTER, F., 1989, Hydrolysis of bisphenol A diglycidylether by epoxide hydrolases in cytosolic and microsomal fractions of mouse liver and skin: inhibition by bis epoxycyclopentylether and the effects upon the covalent binding to mouse skin DNA. Carcinogenesis, 10, 321–327.
  • BOOGAARD, P. J. and BOND, J. A., 1996, The role of hydrolysis in the detoxification of 1,2 :3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicology and Applied Pharmacology, 141, 617–627.
  • BOOGAARD, P. J., SUMNER, S.-C. J. and BOND, J. A., 1996b, Glutathione conjugation of 1,2 : 3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro. Toxicology and Applied Pharmacology, 136, 307–316.
  • BOOGAARD, P. J., SUMNER, S.-C. J., TURNER, M. J. and BOND, J. A., 1996a, Hepatic and pulmonary glutathione conjugation of 1,2 : 3, 4-diepoxybutane in human and rat and mouse in vitro. Toxicology, 113, 297–299.
  • BRONAUGH, R. L. and STEWART, R. F., 1984, Methods for in vitro percutaneous absorption studies. IV: The flow through diffusion cell. Journal of Pharmaceutical Sciences, 74, 64–67.
  • BRONAUGH, R. L., STEWART, R. F. and CONGDON, E. R., 1982a, Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicology and Applied Pharmacology, 62, 481–488.
  • BRONAUGH, R. L., STEWART, R. F., CONGDON, E. R. and GILES, A. L., 1982b, Methods for in vitro percutaneous absorption studies. I. Comparison with in vivo results. Toxicology and Applied Pharmacology, 62, 474–480.
  • CLARK, N. W. E., SCOTT, R. C., BIAIN, P. G. and WILLIAMS, F. M., 1993, Fate of fluazifop butyl in rat and human skin in vitro. Archives of Toxicology, 67,44–48.
  • CLAirE, I. J. G., HUTSON, D. H. and STOYDIN, G., 1981a, Metabolism of the epoxy resin component 2,3-bis [4-(2,3-epoxypropoxy)phenyl]propane, the diglycidyl ether of bisphenol A (DGEBPA) in the mouse. I. A comparison of the fate of a single dermal application and of a single oral dose of 14C-DGEBPA. Xenobiotica, 11, 391–399.
  • CLAirE, I. J. G., HUTSON, D. H. and STOYDIN, G., 1981b, Metabolism of the epoxy resin component 2, 3-bis [4-(2,3-epoxypropoxy)phenyl]propane, the diglycidyl ether of bisphenol A (DGEBPA) in the mouse. II. Identification of metabolites in urine and faeces following of a single oral dose of 14C-DGEBPA. Xenobiotica, 11, 401–424.
  • CSANADY, G. A., GUENGERICH, F. P. and BOND, J. A., 1992, Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis, 13, 1143–1153.
  • GARDINER, T. H., WAECITIER, J. M., WIEDOW, M. A. and SOLOMON, W. T., 1992, Glycidyloxy compounds used in epoxy resin systems: a toxicology review. Regulatory Toxicology and Pharmacology, 15, S1–77.
  • GRUBIC, Z., ST, D. and BRZIN, M., 1988, Iso-OMPA-induced potentiation of soman toxicity in rats correlates with the inhibition of plasma carboxylesterases. Archives of Toxicology, 62, 398–399.
  • GUEST, D. and DENT, J. G., 1980, Effects of epoxide hydratase inhibitors in forward and reversion bacterial mutagenesis assay systems. Environmental Mutagenesis, 2, 27–34.
  • GUPTA, R. C. and DETTBARN, W.-D., 1993, Role of carboxylesterases in the prevention and potentiation of N-methylcarbamate toxicity. Chemico-Biological Interactions, 87, 295–303.
  • HEWITT, P. G., HOTCHKISS, S. A. M. and CALDWELL, J., 1995, Decontamination procedures after in vitro topical exposure of human and rat skin to 4,4-methylenebis[2-chloroaniline] and 4,4--methylenedianiline. Fundamental and Applied Toxicology, 26, 91–98.
  • HEWITT, P., HOTCHKISS, S. A. M., PERKINS, J. M. and ROWE, R. R., 1996, Transdermal metabolism of fluoroxypyr 1-methylheptyl ester during percutaneous absorption through fresh human and rat skin in vitro. Prediction of Percutaneous Penetration, 4B, 303–306.
  • HOTCHKISS, S. A., CHIDGEY, M. A. J., ROSE, S. and CALDWELL, J., 1990, Percutaneous absorption of benzyl acetate through rat skin in vitro. 1. Validation of an in vitro model against in vivo data. Food and Chemical Toxicology, 28, 443–447.
  • HOTCHKISS, S. A., HEwrrr,, P., CALDWELL, J., CHEN, W. L. and ROWE, R. R., 1992, Percutaneous absorption of nicotinic acid, phenol, benzoic acid and triclopyr butoxyethyl ester through rat and human skin in vitro: further validation of an in vitro model by comparison with in vivo data. Food and Chemical Toxicology, 30, 891–899.
  • IARC, 1989, Some Organic Solvents, Resin Monomers and Related Compounds, Pigments and Occupational Exposures in Paint Manufacture and Painting. Some Glycidyl Ethers. Monographs on the Evaluation of Carcinogenic Risks to Humans, 237–61 (Lyon: IARC).
  • INTERNATIONAL Lin E SCIENCE INSTITUTE, 1994, Physiological Parameter Values for PBPK Models. Report prepared by the ILSI Risk Science Institute Working Group on Physiological Parameters (Washington, DC: ILSI).
  • Murirtv, C. A. and HAMMOCK, B. D., 1982, Chalcone oxides—potent selective inhibitors of cytosolic epoxide hydrolase. Archives of Biochemistry and Biophysics, 216, 423–439.
  • Non, A. A., SILVEIRA, D. M., FERRALA, N. F., MARKHAM, P.M., McCowso, M. F., GANAYEM B. I. and CHADWICK, M., 1995. Comparative disposition of 2,3-epoxy-1 -propanol (glycidol) in rats following oral and intravenous administration. Journal of Toxicology and Environmental Health, 44, 203–217.
  • PATEL, J. M., WOOD, J. C. and LEIBMAN, K. C., 1980. The biotransformation of ally' alcohol and acrolein in rat liver and lung preparations. Drug Metabolism and Disposition, 8, 305–308.
  • Ros, A. M. P., KRAMER, P. A., STIL, H. A. and PETRUS, L. 1994. Characterization of the composition of V ersatic-10 by 1D and 2D 13C NMR.. Shell Group Research Report, AMGR. 94. 325 (Amsterdam: Koninldijke/Shell Laboratorium).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.